BOC Inhibitors
BOC inhibitors are a class of chemical compounds that specifically target the BOC protein, a member of the immunoglobulin superfamily involved in cellular communication and signaling. BOC (Brother of CDO) is primarily known for its role in modulating signaling pathways that govern cell differentiation, growth, and tissue development. BOC interacts with other proteins on the surface of cells, particularly in processes like neural development and muscle formation. As a co-receptor, BOC plays a part in the reception and modulation of signals from ligands such as Hedgehog proteins, which are critical for the regulation of cell proliferation and patterning during development. BOC inhibitors are designed to block these interactions, providing valuable tools for studying the role of BOC in these signaling pathways and its impact on cellular processes.
BOC inhibitors are small molecules that bind to the extracellular or intracellular regions of the BOC protein, preventing it from interacting with its signaling partners. By inhibiting BOC function, these compounds disrupt its role in modulating the Hedgehog signaling pathway, which is crucial for controlling gene expression related to development. Researchers use BOC inhibitors to investigate how this protein influences various developmental processes, particularly in the formation and patterning of tissues. The inhibition of BOC helps elucidate the molecular mechanisms of signal transduction, offering insights into how cells interpret external signals to drive processes such as differentiation and tissue organization. BOC inhibitors are thus key tools in understanding the intricate networks of cell signaling and their roles in development and growth regulation.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cyclopamine | 4449-51-8 | sc-200929 sc-200929A | 1 mg 5 mg | $94.00 $208.00 | 19 | |
Cyclopamine could directly inhibit the Sonic hedgehog (Shh) pathway by binding to and antagonizing the Smoothened receptor, which may result in the decreased expression of downstream targets like BOC. | ||||||
Vismodegib | 879085-55-9 | sc-396759 sc-396759A | 10 mg 25 mg | $82.00 $158.00 | 1 | |
Vismodegib, a Smoothened antagonist, directly targets and blocks Hedgehog signaling, potentially leading to a reduction in BOC expression as part of the downstream effect. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid, through its role as an active metabolite of Vitamin A, can downregulate BOC expression by binding to retinoic acid receptors that alter gene transcription processes during cellular differentiation. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits the mTOR pathway, which is crucial for protein synthesis; thus, it could decrease BOC protein production by reducing overall translation efficiency. | ||||||
Spironolactone | 52-01-7 | sc-204294 | 50 mg | $109.00 | 3 | |
Spironolactone might decrease BOC expression by antagonizing aldosterone receptors, leading to altered transcriptional responses in hormone-responsive tissues. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
SB 431542 inhibits TGF-β type I receptor ALK5, which could lead to decreased signaling through the TGF-β pathway and a subsequent downregulation of BOC expression. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY 294002, as a PI3K inhibitor, could reduce the phosphorylation of Akt, leading to a decrease in the transcription of genes like BOC that are downstream in the PI3K/Akt pathway. | ||||||
DAPT | 208255-80-5 | sc-201315 sc-201315A sc-201315B sc-201315C | 5 mg 25 mg 100 mg 1 g | $40.00 $120.00 $480.00 $2141.00 | 47 | |
DAPT, by inhibiting gamma-secretase, could decrease Notch signaling, potentially leading to reduced expression of BOC, as Notch can drive the expression of various genes. | ||||||
Wnt-C59 | 1243243-89-1 | sc-475634 sc-475634A sc-475634B | 5 mg 10 mg 50 mg | $214.00 $326.00 $1275.00 | 1 | |
Wnt-C59 could inhibit the production of Wnt proteins, leading to a decrease in Wnt signaling and a consequent reduction in the expression of target genes, potentially including BOC. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 inhibits ROCK kinase activity, which could lead to changes in gene expression profiles, including the downregulation of BOC expression due to alterations in cellular dynamics. | ||||||